Virax Biolabs Group Limited
VRAXNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $644.10K
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.17$13.34
- Volume (live)
- -
- Avg. volume (3M)
- 150.16K
Virax Biolabs Group (VRAX) Stock Price & Financial Analysis
Virax Biolabs Group Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.38 - $1.64 |
|---|---|
| 52-Week High | $13.34 |
| 52-Week Low | $0.17 |
| Open | $1.62 |
| Volume (last close) | 40.60K |
| Average Volume (3M) | 150.16K |
| Revenue (TTM) | 20.36K |
|---|---|
| Net Income (TTM) | -13.42M |
| Free Cash Flow (TTM) | -13.11M |
| EPS (TTM) | −$60.57 |
| Profit Margin | -65925.59% |
| Operating Margin | -74393.98% |
| Return on Equity (ROE) | -183.01% |
| Debt to Equity | 0.00 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 644.10K |
|---|---|
| Shares Outstanding | 397.59K |
| Price to Sales (P/S) | 31.63 |
| Price to Book (P/B) | 0.09 |
| EV/EBITDA | 0.42 |
| 50-Day MA | $2.57 |
|---|---|
| 200-Day MA | $2.54 |
| 1-Year Change | +166.18% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Virax Biolabs Group at a Glance
As of the Oct 16, 2026 close, Virax Biolabs Group (VRAX) has a market capitalization of $644.10K. The stock trades at 31.6× sales. Over the trailing twelve months it lost $13.42M on revenue of $20.36K and burned $13.11M of free cash flow. Revenue grew 96.2% year over year.
As of its latest reported balance sheet, it holds $6.44M in cash and securities against $28.48K of debt, a net cash position of $6.41M.
Virax Biolabs Group does not currently pay a dividend.
The share price is up 166.2% over the past year. At $1.45 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $0.17 to $13.34, below its 200-day moving average of $2.54.
Frequently Asked Questions About Virax Biolabs Group
What is the current stock price for VRAX?
As of the Oct 16, 2026 close, VRAX stock trades at $1.45. The 52-week range is $0.17–$13.34, with a day range of $1.38–$1.64.
What is the P/E ratio for VRAX?
The P/E ratio (Price-to-Earnings) for VRAX is shown in the Key Statistics section. This valuation metric helps compare Virax Biolabs Group Limited to industry peers.
Does VRAX pay dividends?
Virax Biolabs Group does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for VRAX?
Analyst ratings and recommendations for VRAX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of VRAX?
As of the Oct 16, 2026 close, Virax Biolabs Group's market capitalization is $576,505.5, classifying it as a micro-cap company. Virax Biolabs Group operates in the Healthcare sector within the Biotechnology industry.